Literature DB >> 24308446

Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load.

Christine M Oshansky1, Andrew J Gartland, Sook-San Wong, Trushar Jeevan, David Wang, Philippa L Roddam, Miguela A Caniza, Tomer Hertz, John P Devincenzo, Richard J Webby, Paul G Thomas.   

Abstract

RATIONALE: Children are an at-risk population for developing complications following influenza infection, but immunologic correlates of disease severity are not understood. We hypothesized that innate cellular immune responses at the site of infection would correlate with disease outcome.
OBJECTIVES: To test the immunologic basis of severe illness during natural influenza virus infection of children and adults at the site of infection.
METHODS: An observational cohort study with longitudinal sampling of peripheral and mucosal sites in 84 naturally influenza-infected individuals, including infants. Cellular responses, viral loads, and cytokines were quantified from nasal lavages and blood, and correlated to clinical severity.
MEASUREMENTS AND MAIN RESULTS: We show for the first time that although viral loads in children and adults were similar, innate responses in the airways were stronger in children and varied considerably between plasma and site of infection. Adjusting for age and viral load, an innate immune profile characterized by increased nasal lavage monocyte chemotactic protein-3, IFN-α2, and plasma IL-10 levels at enrollment predicted progression to severe disease. Increased plasma IL-10, monocyte chemotactic protein-3, and IL-6 levels predicted hospitalization. This inflammatory cytokine production correlated significantly with monocyte localization from the blood to the site of infection, with conventional monocytes positively correlating with inflammation. Increased frequencies of CD14(lo) monocytes were in the airways of participants with lower inflammatory cytokine levels.
CONCLUSIONS: An innate profile was identified that correlated with disease progression independent of viral dynamics and age. The airways and blood displayed dramatically different immune profiles emphasizing the importance of cellular migration and localized immune phenotypes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24308446      PMCID: PMC3977720          DOI: 10.1164/rccm.201309-1616OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  34 in total

Review 1.  Immunological memory ≠ protective immunity.

Authors:  Rolf M Zinkernagel
Journal:  Cell Mol Life Sci       Date:  2012-04-06       Impact factor: 9.261

2.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

3.  Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia.

Authors:  Nelson Lee; Paul K S Chan; Chun Kwok Wong; Ka-Tak Wong; Kin-Wing Choi; Gavin M Joynt; Philip Lam; Martin C W Chan; Bonnie C K Wong; Grace C Y Lui; Winnie W Y Sin; Rity Y K Wong; Wai-Yip Lam; Apple C M Yeung; Ting-Fan Leung; Hing-Yu So; Alex W Y Yu; Joseph J Y Sung; David S C Hui
Journal:  Antivir Ther       Date:  2011

4.  Type I interferon inhibits interleukin-1 production and inflammasome activation.

Authors:  Greta Guarda; Marion Braun; Francesco Staehli; Aubry Tardivel; Chantal Mattmann; Irmgard Förster; Matthias Farlik; Thomas Decker; Renaud A Du Pasquier; Pedro Romero; Jürg Tschopp
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

Review 5.  Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).

Authors:  Kay Wang; Matthew Shun-Shin; Peter Gill; Rafael Perera; Anthony Harnden
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

6.  IFITM3 restricts the morbidity and mortality associated with influenza.

Authors:  Aaron R Everitt; Simon Clare; Thomas Pertel; Sinu P John; Rachael S Wash; Sarah E Smith; Christopher R Chin; Eric M Feeley; Jennifer S Sims; David J Adams; Helen M Wise; Leanne Kane; David Goulding; Paul Digard; Verneri Anttila; J Kenneth Baillie; Tim S Walsh; David A Hume; Aarno Palotie; Yali Xue; Vincenza Colonna; Chris Tyler-Smith; Jake Dunning; Stephen B Gordon; Rosalind L Smyth; Peter J Openshaw; Gordon Dougan; Abraham L Brass; Paul Kellam
Journal:  Nature       Date:  2012-03-25       Impact factor: 49.962

7.  Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults.

Authors:  Nelson Lee; Chun Kwok Wong; Paul K S Chan; Martin C W Chan; Rity Y K Wong; Samantha W M Lun; Karry L K Ngai; Grace C Y Lui; Bonnie C K Wong; Sharon K W Lee; Kin Wing Choi; David S C Hui
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

8.  Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.

Authors:  Natalia Hagau; Adriana Slavcovici; Daniel N Gonganau; Simona Oltean; Dan S Dirzu; Erika S Brezoszki; Mihaela Maxim; Constantin Ciuce; Monica Mlesnite; Rodica L Gavrus; Carmen Laslo; Radu Hagau; Magda Petrescu; Daniela M Studnicska
Journal:  Crit Care       Date:  2010-11-09       Impact factor: 9.097

9.  Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients.

Authors:  Aliyah Baluch; Atul Humar; Adrian Egli; Jonathan Gubbay; Luiz Lisboa; Leticia Wilson; Deepali Kumar
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  Cytokine response in pediatric patients with pandemic influenza H1N1 2009 virus infection and pneumonia: comparison with pediatric pneumonia without H1N1 2009 infection.

Authors:  Yeo Hyang Kim; Jung-Eun Kim; Myung Chul Hyun
Journal:  Pediatr Pulmonol       Date:  2011-05-27
View more
  87 in total

1.  Nasal Wash Cytokines during Respiratory Viral Infection in Pediatric Allogeneic Hematopoietic Cell-Transplant Recipients.

Authors:  Tim Flerlage; Aisha Souquette; E Kaitlynn Allen; Timothy Brahm; Jeremy Chase Crawford; Li Tang; Yilun Sun; Gabriela Maron; Joshua Wolf; Brandon Triplett; Paul G Thomas
Journal:  Am J Respir Cell Mol Biol       Date:  2020-09       Impact factor: 6.914

2.  SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.

Authors:  E Kaitlynn Allen; Adrienne G Randolph; Tushar Bhangale; Pranay Dogra; Maikke Ohlson; Christine M Oshansky; Anthony E Zamora; John P Shannon; David Finkelstein; Amy Dressen; John DeVincenzo; Miguela Caniza; Ben Youngblood; Carrie M Rosenberger; Paul G Thomas
Journal:  Nat Med       Date:  2017-07-17       Impact factor: 53.440

3.  Immunity to influenza. Preventing infection and regulating disease.

Authors:  E Kaitlynn Allen; Paul G Thomas
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

4.  Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection.

Authors:  Jackson S Turner; Tingting Lei; Aaron J Schmitz; Aaron Day; José Alberto Choreño-Parra; Luis Jiménez-Alvarez; Alfredo Cruz-Lagunas; Stacey L House; Joaquín Zúñiga; Ali H Ellebedy; Philip A Mudd
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

5.  Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model.

Authors:  Andres J Gonzalez; Emmanuel C Ijezie; Onesmo B Balemba; Tanya A Miura
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

6.  Severe Influenza Is Characterized by Prolonged Immune Activation: Results From the SHIVERS Cohort Study.

Authors:  Sook-San Wong; Christine M Oshansky; Xi-Zhi J Guo; Jacqui Ralston; Timothy Wood; Ruth Seeds; Claire Newbern; Ben Waite; Gary Reynolds; Marc-Alain Widdowson; Q Sue Huang; Richard J Webby; Paul G Thomas
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

7.  Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.

Authors:  Adrienne G Randolph; Wai-Ki Yip; Emma Kaitlynn Allen; Carrie M Rosenberger; Anna A Agan; Stephanie A Ash; Yu Zhang; Tushar R Bhangale; David Finkelstein; Natalie Z Cvijanovich; Peter M Mourani; Mark W Hall; Helen C Su; Paul G Thomas
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

8.  Syndecan-1 Attenuates Lung Injury during Influenza Infection by Potentiating c-Met Signaling to Suppress Epithelial Apoptosis.

Authors:  Rena Brauer; Lingyin Ge; Saundra Y Schlesinger; Timothy P Birkland; Ying Huang; Tanyalak Parimon; Vivian Lee; Bonnie L McKinney; John K McGuire; William C Parks; Peter Chen
Journal:  Am J Respir Crit Care Med       Date:  2016-08-01       Impact factor: 21.405

Review 9.  The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis.

Authors:  Mubing Duan; Margaret L Hibbs; Weisan Chen
Journal:  Immunol Cell Biol       Date:  2016-09-27       Impact factor: 5.126

10.  Enhanced viral replication and modulated innate immune responses in infant airway epithelium following H1N1 infection.

Authors:  Candice C Clay; J Rachel Reader; Joan E Gerriets; Theodore T Wang; Kevin S Harrod; Lisa A Miller
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.